BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yaprak O, Acar S, Ertugrul G, Dayangac M. Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation. World J Gastrointest Oncol 2018; 10(10): 336-343 [PMID: 30364796 DOI: 10.4251/wjgo.v10.i10.336]
URL: https://www.wjgnet.com/1948-5204/full/v10/i10/336.htm
Number Citing Articles
1
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and managementLiver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
2
Seok-Hwan Kim, Deok-Bog Moon, Gil-Chun Park, Sung-Gyu Lee, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Young-In Yoon, Hwa-Jung Kim. Preoperative prediction score of hepatocellular carcinoma recurrence in living donor liver transplantation: Validation of SNAPP score developed at Asan Medical CenterAmerican Journal of Transplantation 2021; 21(2): 604 doi: 10.1111/ajt.16227
3
Shengpan Jiang, Xiaoqing Gao, Yueli Tian, Jie Chen, Yichun Wang, Yaqun Jiang, Yong He. The potential of 18F-FDG PET/CT metabolic parameter-based nomogram in predicting the microvascular invasion of hepatocellular carcinoma before liver transplantationAbdominal Radiology 2024; 49(5): 1444 doi: 10.1007/s00261-023-04166-8
4
Sirish A. Kishore, Michael J. Drabkin, Constantinos T. Sofocleous. Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and ResponsePET Clinics 2019; 14(4): 427 doi: 10.1016/j.cpet.2019.06.006
5
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal MalignanciesRadiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
6
Thomas Winkens, William Rudakoff, Falk Rauchfuss, Christina Malessa, Utz Settmacher, Martin Freesmeyer. FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma—Additional Benefit for Patients Considered for Liver Transplantation?Clinical Nuclear Medicine 2021; 46(7): 532 doi: 10.1097/RLU.0000000000003576
7
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
8
Edouard Reizine, Julia Chalaye, Sebastien Mule, Helene Regnault, Clara Perrin, Julien Calderaro, Alexis Laurent, Giuliana Amaddeo, Hicham Kobeiter, Vania Tacher, Emmanuel Itti, Alain Luciani. Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular CarcinomaAmerican Journal of Roentgenology 2022; 218(2): 359 doi: 10.2214/AJR.21.26485
9
Xu Zhang, Chi Chen, Yan Wang, Jun Xu. Recurrence risk prediction models for hepatocellular carcinoma after liver transplantationJournal of Gastroenterology and Hepatology 2024; 39(11): 2272 doi: 10.1111/jgh.16693
10
Filiz Çelebi, Aysegül Görmez, Ahmet Serkan Ilgun, Yaman Tokat, Numan Cem Balcı. The value of 18F-FDG PET/MRI in prediction of microvascular invasion in hepatocellular carcinomaEuropean Journal of Radiology 2022; 149: 110196 doi: 10.1016/j.ejrad.2022.110196
11
Masatoshi Kudo. Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular CarcinomaLiver Cancer 2022; 11(5): 399 doi: 10.1159/000526163
12
Bedriye Koyuncu Sökmen, Nagihan Inan. 18 F-FDG PET/MRI of Primary Hepatic Malignancies: Differential Diagnosis and Histologic GradingCurrent Medical Imaging Formerly Current Medical Imaging Reviews 2023; 20 doi: 10.2174/1573405620666230508105758
13
Raluca Mititelu, Alexandru Mitoi, Catalin Mazilu, Mariana Jinga, Florentina Ionita Radu, Ana Bucurica, Teodora Mititelu, Sandica Bucurica. Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT in diagnosing portal vein tumor thrombosisNuclear Medicine Communications 2024; 45(8): 651 doi: 10.1097/MNM.0000000000001863
14
Jae Hyun Yoon, Sung Kyu Choi. Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomesJournal of Liver Cancer 2023; 23(2): 300 doi: 10.17998/jlc.2023.08.27
15
Yi Wei, Zixing Huang, Hehan Tang, Liping Deng, Yuan Yuan, Jiaxing Li, Dongbo Wu, Xiaocheng Wei, Bin Song. IVIM improves preoperative assessment of microvascular invasion in HCCEuropean Radiology 2019; 29(10): 5403 doi: 10.1007/s00330-019-06088-w
16
Omar Dzaye, Francois H. Cornelis, Henry S. Kunin, Constantinos T. Sofocleous. Advancements and Future Outlook of PET/CT-Guided InterventionsTechniques in Vascular and Interventional Radiology 2023; 26(3): 100916 doi: 10.1016/j.tvir.2023.100916
17
Filiz Çelebi, Kourosh Yaghouti, Emetullah Cindil, Gülen Bülbül Dogusoy, Yaman Tokat, Cem Balcı. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic NeoplasmsAcademic Radiology 2021; 28(2): 189 doi: 10.1016/j.acra.2020.01.026
18
Vincenzo Mazzaferro, Marianna Maspero, Carlo Sposito. Transplant Oncology2025; : 3 doi: 10.1016/B978-0-443-21901-6.00001-X
19
Ender Anılır, Alihan Oral, Fatih Turker, Tolga Şahin, Feyza Sönmez Topçu, Yıldıray Yuzer, Yaman Tokat. Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography–Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular CancerTransplantation Proceedings 2024; 56(1): 111 doi: 10.1016/j.transproceed.2023.12.007
20
Satoru Hagiwara, Naoshi Nishida, Masatoshi Kudo. Advances in Immunotherapy for Hepatocellular CarcinomaCancers 2023; 15(7): 2070 doi: 10.3390/cancers15072070
21
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II RecommendationsJournal of Clinical and Experimental Hepatology 2020; 10(1): 43 doi: 10.1016/j.jceh.2019.09.007
22
Silvio Nadalin, Lara Genedy, Alfred Königsrainer. Ethical Challenges in Cancer Diagnosis and TherapyRecent Results in Cancer Research 2021; 218: 135 doi: 10.1007/978-3-030-63749-1_10
23
Pierluigi Toniutto, Elisa Fumolo, Ezio Fornasiere, Davide Bitetto. Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive ReviewJournal of Clinical Medicine 2021; 10(17): 3932 doi: 10.3390/jcm10173932
24
Francesco Paolo Russo, Alberto Zanetto. Textbook of Liver Transplantation2022; : 389 doi: 10.1007/978-3-030-82930-8_22
25
Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, Kaoru Tsuchiya, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Naoshi Nishida, Chikara Ogawa, Tetsu Tomonari, Noriaki Nakamura, Hidekatsu Kuroda, Atsushi Takebe, Yoshifumi Takeyama, Masaaki Hidaka, Susumu Eguchi, Stephen L Chan, Masayuki Kurosaki, Namiki Izumi. Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept StudyLiver Cancer 2023; 12(4): 321 doi: 10.1159/000529574
26
Shohei Fukai, Hiromitsu Daisaki, Naoki Shimada, Mitsutomi Ishiyama, Takuro Umeda, Kosuke Yamashita, Noriaki Miyaji, Tomohiro Takiguchi, Hideyuki Kawakami, Takashi Terauchi. Evaluation of data-driven respiratory gating for subcentimeter lesions using digital PET/CT system and three-axis motion phantomBiomedical Physics & Engineering Express 2023; 9(1): 015006 doi: 10.1088/2057-1976/aca90d